{'52WeekChange': -0.59951454,
 'SandP52WeekChange': 0.0644362,
 'address1': 'One Newton Executive Park',
 'address2': 'Suite 202',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 1.7,
 'askSize': 1400,
 'averageDailyVolume10Day': 4031512,
 'averageVolume': 1174382,
 'averageVolume10days': 4031512,
 'beta': 2.895287,
 'beta3Year': None,
 'bid': 1.64,
 'bidSize': 2900,
 'bookValue': 0.431,
 'category': None,
 'circulatingSupply': None,
 'city': 'Newton',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 1.7,
 'dayLow': 1.61,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -0.697,
 'enterpriseToRevenue': None,
 'enterpriseValue': 29783540,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '617-916-1871',
 'fiftyDayAverage': 1.6745714,
 'fiftyTwoWeekHigh': 6.3,
 'fiftyTwoWeekLow': 0.525,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 9225357,
 'forwardEps': -0.96,
 'forwardPE': -1.71875,
 'fromCurrency': None,
 'fullTimeEmployees': 33,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.10155,
 'heldPercentInstitutions': 0.61649,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/allenapharma.com',
 'longBusinessSummary': 'Allena Pharmaceuticals, Inc., a late-stage clinical '
                        'biopharmaceutical company, engages in the development '
                        'and commercialization of oral enzyme therapeutics to '
                        'treat patients with rare and severe metabolic, and '
                        'kidney disorders in the United States and '
                        "internationally. The company's lead product candidate "
                        'is reloxaliase, an oral enzyme therapeutic for the '
                        'treatment of enteric hyperoxaluria, a metabolic '
                        'disorder commonly associated with kidney stones in '
                        'adults. It also develops ALLN-346 for patients with '
                        'hyperuricemia and moderate to severe chronic kidney '
                        'diseases. The company was founded in 2011 and is '
                        'headquartered in Newton, Massachusetts.',
 'longName': 'Allena Pharmaceuticals, Inc.',
 'market': 'us_market',
 'marketCap': 53129836,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_143094845',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -43505000,
 'nextFiscalYearEnd': 1640908800,
 'open': 1.7,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '617-467-4577',
 'previousClose': 1.67,
 'priceHint': 4,
 'priceToBook': 3.8283062,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 1.7,
 'regularMarketDayLow': 1.61,
 'regularMarketOpen': 1.7,
 'regularMarketPreviousClose': 1.67,
 'regularMarketPrice': 1.7,
 'regularMarketVolume': 600013,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 24882900,
 'sharesPercentSharesOut': 0.0161,
 'sharesShort': 518120,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 293902,
 'shortName': 'Allena Pharmaceuticals, Inc.',
 'shortPercentOfFloat': 0.020499999,
 'shortRatio': 0.37,
 'startDate': None,
 'state': 'MA',
 'strikePrice': None,
 'symbol': 'ALNA',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.878,
 'twoHundredDayAverage': 1.7882806,
 'volume': 600013,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.allenapharma.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '02462'}